University of Cambridge
Insight

Jason Mellad, CEO of spin-out Cambridge Epigenetix, discusses commercialising University research

29 November 2017
Insight

Professor Jim Huntington shares his commercial journey with University of Cambridge researchers

18 July 2017
XO1
Case Studies

X01 and a ground-breaking drug candidate

20 October 2015